Department of Neurology, SUNY Downstate Medical Center, New York Headache Center, New York, NY, USA | Department of Neurology, SUNY Downstate Medical Center, New York Headache ...
KOL Resume for Alexander Mauskop
Department of Neurology, SUNY Downstate Medical Center, New York Headache Center, New York, NY, USA
Department of Neurology, SUNY Downstate Medical Center, New York Headache Center, New York, NY, USA.
New York Headache Center, Department of Neurology, SUNY Downstate Medical Center, New York, New York, USA
New York Headache Center, 10021, New York, NY, USA
Neurology, New York Headache Center, New York, NY, USA.
New York Headache Center, 30 East 76 Street, 10021, New York, NY, USA
SUNY Downstate Medical Center, New York, NY, USA
New York Headache Center and Downstate Medical Center, State University of New York, New York, NY, USA
New York Headache Center, New York, New York
Department of Clinical Neurology, SUNY Downstate Medical Center; New York Headache Center, 30 East 76th Street, New York, NY 10021
From the University of Cincinnati, Cincinnati, OH, USA (Dr. Martin); Headache Care Center, Springfield, MO, USA (Dr. Cady); New York Headache Center, New York, NY, USA (Dr. Mauskop); Philadelphia Women's Research, Philadelphia, PA, USA (Dr. Seidman); Merck & Co., Inc., West Point, PA, USA (Drs. Rodgers, Hustad, Ramsey, and Skobieranda)
New York Headache Center, New York, NY, USA.
University of Cincinnati, Cincinnati, OH (Martin)
New York Headache Center, & SUNY-Downstate Medical Center, New York, NY, USA.
State University of New York, Downstate Medical Center, Brooklyn, NY, USA.
New York Headache Center, New York, NY 10021, USA.
From The New York Headache Center
Weber & Weber GmbH & Co. KG
New York Headache Center, New York, USA.
New York Headache Center, New York, 11201, USA
New York Headache Center, 30 East 76 Street, 10021, New York, New York, USA
Headache Center New York NY
Department of Neurology, State University of New York, Health Science Center at Brooklyn,
Departments of Neurology and Physiology, State University of New York, Health Science Center at Brooklyn, U.S.A.
Departments of Neurology
New York Headache Center, New York, USA
New York Headache Center, New York City, New York, USA
Director of the New York Headache Center, New York, New York USA
Alexander Mauskop: Influence Statistics
|migraines migraine disorders||#1|
|migraine patients magnesium||#1|
|order clinician preference||#1|
|magnesium magnesium deficiency||#1|
|intravenous emergency service||#1|
|headaches alternative approaches||#1|
|magnesium migraine headaches||#1|
|physical treatments response||#1|
|tensiontype headaches tths||#1|
|supplements migraine treatment||#1|
|psilocybin headache treatment||#1|
|behavioral physical treatments||#1|
|food triggers vitamins||#1|
|response physical treatments||#1|
|patients cluster headaches||#1|
|alternative headache treatments||#1|
|supplements migraine headaches||#1|
|massage chiropractic therapy||#1|
|αlipoic acid butterbur||#1|
|treatment scientific proof||#1|
|migraine sufferers magnesium||#1|
|headaches complementary modes||#1|
|pathogenesis migraine headaches||#1|
|physicians potential efficacy||#1|
|complementary modes patients||#1|
Open the FULL List in Excel
Prominent publications by Alexander Mauskop
Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double‐Blind, Placebo‐Controlled Study
[ PUBLICATION ]
OBJECTIVE: To assess the efficacy and safety of botulinum toxin type A (BoNT-A; BOTOX, Allergan, Inc., Irvine, CA) for the prophylaxis of headaches in patients with chronic daily headache (CDH) without the confounding factor of concurrent prophylactic medications.
BACKGROUND: Several open-label studies and an 11-month, randomized, double-blind, placebo-controlled study suggest that BoNT-A may be an effective therapy for the prophylaxis of headaches in patients with CDH.
DESIGN AND ...
|Known for Chronic Daily Headache | Baseline Bonta | Prophylactic Medications | Botulinum Toxin Type | Patients Cdh|
Use of chronic opioid therapy for chronic noncancer pain has increased substantially. The American Pain Society and the American Academy of Pain Medicine commissioned a systematic review of the evidence on chronic opioid therapy for chronic noncancer pain and convened a multidisciplinary expert panel to review the evidence and formulate recommendations. Although evidence is limited, the expert panel concluded that chronic opioid therapy can be an effective therapy for carefully selected ...
|Known for Chronic Opioid Therapy | Clinical Guidelines | Recommendations Evidence | Expert Panel | Opioidrelated Adverse Effects|
OBJECTIVE: To determine if administration of rizatriptan 10 mg is superior to placebo for the early treatment of acute migraine, while the pain is mild.
BACKGROUND: Past studies have suggested that treatment outcomes can be improved if a triptan is administered early in the time course of a migraine attack.
METHODS: Two randomized, parallel, placebo-controlled, double-blind studies. TAME (Treat A Migraine Early)1 was conducted at 46 centers in the United States; TAME2, at 48 centers in ...
|Known for Migraine Attack | Pain Freedom | 2 Hours | Rizatriptan 10 | United States|
Efficacy of Rizatriptan for Menstrual Migraine in an Early Intervention Model: A Prospective Subgroup Analysis of the Rizatriptan TAME (Treat A Migraine Early) Studies
[ PUBLICATION ]
OBJECTIVE: A prospective subgroup analysis of the TAME (Treat A Migraine Early) studies examined the efficacy of rizatriptan in patients treating a menstrual migraine attack.
METHODS: Both TAME studies were randomized, placebo-controlled, and double-blind. Adults with migraine were assigned (2:1) to either rizatriptan 10-mg tablet or placebo. Patients were instructed to treat within 1 hour of migraine onset and when the pain was mild. The primary endpoint was 2-hour pain freedom. The ...
|Known for Menstrual Migraine | Early Intervention | Menstruation Disturbances | Tame Studies | Hour Pain|
Long‐Term Migraine Prevention With Topiramate: Open‐Label Extension of Pivotal Trials
[ PUBLICATION ]
OBJECTIVE: To demonstrate that topiramate is an effective and generally well-tolerated migraine preventive therapy when used for up to 14 months.
BACKGROUND: Topiramate 100 and 200 mg/d significantly reduced mean monthly migraine frequency during 2 large, 26-week, randomized, placebo-controlled trials. Only a small number of clinical trials have examined the long-term (> or =1 year) effectiveness and safety of migraine preventive therapies.
METHODS: Five hundred sixty-seven patients with ...
|Known for Patients Topiramate | Doubleblind Phase | Migraine Prevention | Label Extension | Fructose Humans|
Petasites hybridus root (butterbur) is an effective preventive treatment for migraine
[ PUBLICATION ]
OBJECTIVE: To evaluate the clinical efficacy of a standardized special root extract from the plant Petasites hybridus as a preventive therapy for migraine.
METHODS: This is a three-arm, parallel-group, randomized trial comparing Petasites extract 75 mg bid, Petasites extract 50 mg bid, or placebo bid in 245 patients with migraine. Eligible patients met International Headache Society criteria for migraine, were ages 18 to 65, and had at least two to six attacks per month over the ...
|Known for Petasites Hybridus | Preventive Treatment | Patients Migraine | 50 Reduction | Plant Roots|
Zolmitriptan is Effective for the Treatment of Persistent and Recurrent Migraine Headache
[ PUBLICATION ]
Zolmitriptan is a 5-HT1B/1D receptor agonist for the acute treatment of migraine. This study examined the efficacy of a second dose of zolmitriptan for the treatment of persistent or recurrent headache. Part 1 was a randomised, placebo-controlled, double-blind evaluation of 2.5 mg and 5 mg zolmitriptan for the treatment of persistent migraine headache, two hours after an initial dose of 2.5 mg zolmitriptan. In part 2 (open-label), patients treated the first two attacks with 2.5 mg ...
|Known for Zolmitriptan Patients | Migraine Headache | 25 5 | Acute Treatment | Pain Free|
Sumatriptan/Naproxen Sodium for Migraine: Efficacy, Health Related Quality of Life, and Satisfaction Outcomes
[ PUBLICATION ]
OBJECTIVE: To describe the pain relief, satisfaction, and health-related quality of life results of moderate or severe migraines treated with a sumatriptan/naproxen sodium combination tablet.
METHODS: Sumatriptan and naproxen sodium as a single-dose formulation tablet was used to treat moderate to severe migraines over a 12-month period in a phase 3, open-label, multicenter study (n = 565) in patients with at least 6 months' history of migraine headaches.
RESULTS: Seventy percent of all ...
|Known for Naproxen Sodium | Satisfaction Outcomes | Migraine Attacks | Quality Life | Pain Relief|
There is a growing body of evidence supporting the efficacy of various complementary and alternative medicine approaches in the management of headache disorders. These treatment modalities include nutraceutical, physical and behavioral therapies. Nutraceutical options comprise vitamins and supplements (magnesium, riboflavin, coenzyme Q(10), and alpha lipoic acid) and herbal preparations (feverfew, and butterbur). Although controversial, there are some reports demonstrating the benefit of ...
|Known for Headache Treatment | Physical Therapy | Growing Body | Herbal Preparations | Relaxation Training|
Anticonvulsant and antidepressant medications have demonstrated efficacy in migraine treatment. Vagus nerve stimulation (VNS) is an effective treatment for drug-refractory epilepsy and possibly depression and it also has documented analgesic effects. These observations suggested a possible role for VNS in treating severe refractory headaches, and led to a trial of VNS in patients with such headaches. VNS was implanted in four men and two women with disabling chronic cluster and migraine ...
|Known for Cluster Headaches | Nerve Stimulation | Vns Patients | Refractory Migraine | Intractable Chronic|
Magnesium is an important intracellular element that is involved in numerous cellular functions. Deficiencies in magnesium may play an important role in the pathogenesis of migraine headaches by promoting cortical spreading depression, alteration of neurotransmitter release and the hyperaggregation of platelets. Given this multifaceted role of magnesium in migraine, the use of magnesium in both acute and preventive headache treatment has been researched as a potentially simple, ...
|Known for Magnesium Migraine | Pathogenesis Treatment | Neurotransmitter Release | Spreading Depression | Emphasis Role|
OBJECTIVE: Although a wide range of acute and preventative medications are now available for the treatment of migraine headaches, many patients will not have a significant improvement in the frequency and severity of their headaches unless lifestyle modifications are made. Also, given the myriad side effects of traditional prescription medications, there is an increasing demand for "natural" treatment like vitamins and supplements for common ailments such as headaches. Here, we discuss ...
|Known for Migraine Headaches | Food Triggers | Lifestyle Modifications | Dietary Supplements | Preventative Treatment|
Key People For Menstrual Migraine
Alexander Mauskop:Expert Impact
Concepts for whichAlexander Mauskophas direct influence:Menstrual migraine, Botulinum toxin, Magnesium deficiency, Cluster headaches, Migraine headaches, Chronic opioid therapy, Trigeminal neuralgia, Ionized magnesium.
Alexander Mauskop:KOL impact
Concepts related to the work of other authors for whichfor which Alexander Mauskop has influence:Chronic pain, Opioid therapy, Botulinum toxin, Vagus nerve, Migraine patients, Cluster headache, Acute treatment.
Is this your profile? Claim your profile Copy URL Embed Link to your profile